Skip to main content
Psychopharmacology Bulletin › All Volumes & Issues › VOL 36 No. 4 › Management of Bipolar...
GENERAL PSYCHOPHARMACOLOGY

Management of Bipolar Disease in Children and Adolescents

Karen Dineen Wagner, MD, PhD
Psychopharmacology Bulletin 36(4): 151-159, 2002/10/15; https://doi.org/10.64719/pb.4209

Abstract

Bipolar disorder is a serious condition that adversely affects social, emotional, academic, and family functioning in children and adolescents with the disorder. Despite the severity of this illness, there is very little data to guide treatment decisions in the management of bipolar disorder in youth. The majority of information available about pharmacological treatments for bipolar disorder in children and adolescents relies upon open studies, case series, and case reports. In this article, data on medications for the treatment of bipolar disorder in children and adolescents are presented, and clinical recommendations are discussed. Psychopharmacology Bulletin. 2002;36(4):151-159

Keywords

carbamazepine, divalproex, gabapentin, lamotrigine, lithium, olanzapine, quetiapine, risperidone, topiramate

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In
Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Karen Dineen Wagner, MD, PhD. Management of Bipolar Disease in Children and Adolescents. Psychopharmacology Bulletin. 2002/10/15; 36(4):151-159. https://doi.org/10.64719/pb.4209